Importantly, exposure to UCB could reduce PGK1 and ALDOA levels in Th17 cells derived from the peripheral blood of healthy controls, after challenge with high concentration glucose; whereas such an effect was not present when considering Th17 cells derived from Crohn’s disease patients (Fig. 3f and Supplementary Fig. 3c, d). This evidence concerns the gene ALDOA and Crohn disease.